Literature DB >> 4008047

Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein.

E W Carrow, J E Domer.   

Abstract

Immune regulation in candidiasis is inferred from studies of both human and animal infection, with a suppressive role suggested for cell wall polysaccharide. To study the immunosuppressive potential of Candida albicans in a murine model, whole blastoconidia or purified cell wall components of C. albicans were tested for their effects on the development of acquired immune responses by superimposing a pretreatment regimen upon an established immunization protocol. CBA/J or BALB/cByJ mice were pretreated twice intravenously with 100 micrograms of mannan (MAN), 100 or 200 micrograms of glycoprotein (GP), or 5 X 10(7) heat-killed C. albicans blastoconidia, followed 1 week later by an immunization protocol of two cutaneous inoculations of viable C. albicans blastoconidia given 2 weeks apart. Delayed hypersensitivity (DTH) to GP or to a membrane-derived antigen, B-HEX, was tested 7 days after the second inoculation, and lymphocyte stimulation was tested with mitogens and Candida antigens after 12 days. To assess protection, mice were challenged intravenously with viable C. albicans blastoconidia 14 days after the second cutaneous inoculation and sacrificed 28 days later for quantitative culture of kidneys and brains. Sera were obtained for enzyme-linked immunosorbent assays at selected intervals. Pretreatment with GP resulted in specific in vivo suppression of DTH to GP but not to B-HEX antigen and specific in vitro suppression of lymphocyte stimulation to GP but not to other Candida antigens or mitogens. MAN and heat-killed C. albicans blastoconidia had no such effects. GP pretreatment also diminished the protective effect of immunization against challenge, demonstrable in the brain, while not altering significantly the production of antibody in response to infection. Contrary to clinical evidence, MAN was not immunosuppressive in this model, and in fact, the immunosuppressive potential of GP, which is composed largely of MAN, was found to be dependent upon the presence of its heat-labile protein moiety.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008047      PMCID: PMC262075          DOI: 10.1128/iai.49.1.172-181.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Physical and chemical properties of polysaccharides and glycoproteins of the yeast-cell wall.

Authors:  E D KORN; D H NORTHCOTE
Journal:  Biochem J       Date:  1960-04       Impact factor: 3.857

2.  Suppression of lymphocyte blastogenesis by Candida albicans.

Authors:  T J Rogers; E Balish
Journal:  Clin Immunol Immunopathol       Date:  1978-07

3.  Variation in lymphocyte reactivity to histoplasmin during the course of chronic pulmonary histoplasmosis.

Authors:  R H Alford; R A Goodwin
Journal:  Am Rev Respir Dis       Date:  1973-07

Review 4.  Chronic mucocutaneous candidiasis: model-building in cellular immunity.

Authors:  C H Kirkpatrick; R R Rich; J E Bennett
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

5.  Suppressor thymus-derived lymphocytes in fungal infection.

Authors:  J D Stobo; S Paul; R E Van Scoy; P E Hermans
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

6.  Nature of the skin-reactive principle in culture filtrates prepared from Paracoccidioides brasiliensis.

Authors:  A Restrepo-Moreno; J D Schneidau
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

7.  Effect of systemic candidiasis on blastogenesis of lymphocytes from germfree and conventional rats.

Authors:  T J Rogers; E Balish
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

8.  Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.

Authors:  D K Giger; J E Domer; J T McQuitty
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Biological and chemical characterization of toxic substances from Candida albicans.

Authors:  J E Cutler; L Friedman; K C Milner
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

10.  Immunotherapy of coccidioidomycosis.

Authors:  A Catanzaro; L Spitler; K M Moser
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

View more
  22 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis.

Authors:  R A Cox; W Kennell; L Boncyk; J W Murphy
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 3.  Recurrent genital tract infection: a result of induced immunosuppression?

Authors:  C Sonnex
Journal:  Genitourin Med       Date:  1989-12

4.  Altered hepatic clearance and killing of Candida albicans in the isolated perfused mouse liver model.

Authors:  R T Sawyer; M N Horst; R E Garner; J Hudson; P R Jenkins; A L Richardson
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.

Authors:  R E Garner; J E Domer
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 6.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

7.  Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues.

Authors:  N Shibata; M Arai; E Haga; T Kikuchi; M Najima; T Satoh; H Kobayashi; S Suzuki
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Immunosuppressive effects of Centipeda periodontii: selective cytotoxicity for lymphocytes and monocytes.

Authors:  B J Shenker; P Berthold; P Dougherty; K K Porter
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

9.  Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex.

Authors:  R B Ashman
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.